BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36566599)

  • 1. Hypermethylation in the promoter region inhibits AJAP1 expression and activates the JAK/STAT pathway to promote prostate cancer cell migration and stem cell sphere formation.
    Chen L; Wang Y; Zhang B
    Pathol Res Pract; 2023 Jan; 241():154224. PubMed ID: 36566599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OTX1 silencing suppresses ovarian cancer progression through inhibiting the JAK/STAT signaling.
    Zhang Q; Li X; Ren L; Gu X; Xiao N; Li N
    Tissue Cell; 2023 Jun; 82():102082. PubMed ID: 37027968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FRZB is Regulated by the Transcription Factor EGR1 and Inhibits the Growth and Invasion of Triple-Negative Breast Cancer Cells by Regulating the JAK/STAT3 Pathway.
    Liu H; Mei Y; Ma X; Zhang X; Nie W
    Clin Breast Cancer; 2022 Oct; 22(7):690-698. PubMed ID: 35787980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-552 promotes the proliferation, migration and EMT of hepatocellular carcinoma cells by inhibiting AJAP1 expression.
    Qu W; Wen X; Su K; Gou W
    J Cell Mol Med; 2019 Feb; 23(2):1541-1552. PubMed ID: 30597727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
    Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
    Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MTSS1 hypermethylation is associated with prostate cancer progression.
    Chen J; Huang L; Zhu Q; Wang Z; Tang Z
    J Cell Physiol; 2020 Mar; 235(3):2687-2697. PubMed ID: 31541465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SRRM1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by regulating the JAK/STAT signaling pathway.
    Song X; Ma J
    Tissue Cell; 2022 Dec; 79():101954. PubMed ID: 36270072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylation.
    Tan W; Wang L; Ma Q; Qi M; Lu N; Zhang L; Han B
    Prostate; 2015 Aug; 75(11):1197-205. PubMed ID: 25877612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells.
    Mathews LA; Hurt EM; Zhang X; Farrar WL
    Mol Cancer; 2010 Oct; 9():267. PubMed ID: 20929579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
    Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
    Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of
    Zhang P; Li Z; Yang G
    Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34713300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
    Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H
    Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA AB073614 induces epithelial- mesenchymal transition of colorectal cancer cells via regulating the JAK/STAT3 pathway.
    Xue J; Liao L; Yin F; Kuang H; Zhou X; Wang Y
    Cancer Biomark; 2018; 21(4):849-858. PubMed ID: 29439310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-520a-3p suppresses epithelial-mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1-mediated JAK/STAT signaling pathway.
    Bi CL; Zhang YQ; Li B; Guo M; Fu YL
    J Cell Physiol; 2019 Apr; 234(4):4054-4067. PubMed ID: 30206929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA FGF14-AS2 represses growth of prostate carcinoma cells via modulating miR-96-5p/AJAP1 axis.
    Li R; Chen Y; Wu J; Cui X; Zheng S; Yan H; Wu Y; Wang F
    J Clin Lab Anal; 2021 Nov; 35(11):e24012. PubMed ID: 34655124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [SLC12A8 promotes proliferation, invasiveness, migration and epithelial-mesenchymal transition of bladder cancer cells by activating JAK/STAT singaling].
    Zhang X; Wu H; Wang S
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Sep; 43(9):1613-1621. PubMed ID: 37814877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Epigenetic Modifier 5-Aza-2-deoxycytidine Triggers the Expression of
    Dudzik P; Trojan SE; Ostrowska B; Zemanek G; Dulińska-Litewka J; Laidler P; Kocemba-Pilarczyk KA
    Anticancer Res; 2019 May; 39(5):2395-2403. PubMed ID: 31092432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic silencing of Rab39a promotes epithelial to mesenchymal transition of cervical cancer through AKT signaling.
    Zou C; Fan J; He M; Xu Y; Wang K; Cai Y; Li M
    Exp Cell Res; 2019 May; 378(2):139-148. PubMed ID: 30826396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of
    Jiang L; Liu Y; Pan Y; Tan Z; Wang J; Zheng G; Qian C; Xu S; Zhu X; Ma W; Guerrini S; Infante-Cossio P; Wu J; Ge M; Cai X
    Gland Surg; 2023 Jun; 12(6):834-852. PubMed ID: 37441023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR/EGFRvIII remodels the cytoskeleton via epigenetic silencing of AJAP1 in glioma cells.
    Yang C; Li YS; Wang QX; Huang K; Wei JW; Wang YF; Zhou JH; Yi KK; Zhang KL; Zhou BC; Liu C; Zeng L; Kang CS
    Cancer Lett; 2017 Sep; 403():119-127. PubMed ID: 28634045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.